Published in Circulation on March 15, 1995
Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol (2010) 2.90
Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol (2009) 2.49
Sex differences in mortality following acute coronary syndromes. JAMA (2009) 2.17
Physician board certification and the care and outcomes of elderly patients with acute myocardial infarction. J Gen Intern Med (2006) 1.82
The effect of a charted history of depression on emergency department triage and outcomes in patients with acute myocardial infarction. CMAJ (2011) 1.66
Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart. Circulation (2010) 1.56
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction. Crit Care Med (2011) 1.50
Performance of the Thrombolysis in Myocardial Infarction (TIMI) ST-elevation myocardial infarction risk score in a national cohort of elderly patients. Am Heart J (2005) 1.48
Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial. CMAJ (2012) 1.45
Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J (2014) 1.44
Fibrinolytic treatment for elderly patients with acute myocardial infarction. Heart (2002) 1.39
A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart (2003) 1.35
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart (2001) 1.32
Depression and prognosis following hospital admission because of acute myocardial infarction. CMAJ (2003) 1.25
Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis. Cardiovasc Diabetol (2013) 1.17
Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol (2013) 1.16
Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis. Heart (2002) 1.01
Assessing response bias from missing quality of life data: the Heckman method. Health Qual Life Outcomes (2004) 1.00
Post-acute service use following acute myocardial infarction in the elderly. Health Care Financ Rev (2002) 0.96
Myocardial infarction in the elderly. Aging Dis (2010) 0.96
Early arterial hypotension is common in the post-cardiac arrest syndrome and associated with increased in-hospital mortality. Resuscitation (2008) 0.96
A simple benchmark for evaluating quality of care of patients following acute myocardial infarction. Heart (2001) 0.95
Comparison of clinical outcomes following acute myocardial infarctions in hypertensive patients with or without diabetes. Korean Circ J (2009) 0.95
Simple four-variable screening tool for identification of patients with sleep-disordered breathing. Sleep (2009) 0.94
Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention. World J Emerg Med (2014) 0.92
Paradoxical association of smoking with in-hospital mortality among patients admitted with acute ischemic stroke. J Am Heart Assoc (2013) 0.90
Impact of Health Insurance Expansions on Nonelderly Adults With Hypertension. Prev Chronic Dis (2015) 0.90
In vivo human left-to-right ventricular differences in rate adaptation transiently increase pro-arrhythmic risk following rate acceleration. PLoS One (2012) 0.89
Modern risk stratification in coronary heart disease. J Med Life (2011) 0.88
Percutaneous coronary intervention in elderly patients: is it beneficial? Tex Heart Inst J (2011) 0.88
The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. Eur Heart J Acute Cardiovasc Care (2013) 0.88
Gender differences in patients with acute ST-elevation myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol (2009) 0.88
Sex-based prognostic implications of nonobstructive coronary artery disease: results from the international multicenter CONFIRM study. Radiology (2014) 0.86
Predictive accuracy of risk factors and markers: a simulation study of the effect of novel markers on different performance measures for logistic regression models. Stat Med (2012) 0.86
STEMI and heart failure in the elderly: role of adverse remodeling. Heart Fail Rev (2010) 0.86
Evaluation of arterial stiffness for predicting future cardiovascular events in patients with ST segment elevation and non-ST segment elevation myocardial infarction. ScientificWorldJournal (2013) 0.85
Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicine. Vasc Health Risk Manag (2010) 0.85
Outcomes research in the development and evaluation of practice guidelines. BMC Health Serv Res (2002) 0.85
Prognostic significance of incident atrial fibrillation following STEMI depends on the timing of atrial fibrillation. Neth Heart J (2015) 0.84
Impact of hypertension on short- and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes. Heart Vessels (2011) 0.83
One-year Mortality after an Acute Coronary Event and its Clinical Predictors: The ERICO Study. Arq Bras Cardiol (2015) 0.83
The influence of renal function on the association of rs854560 polymorphism of paraoxonase 1 gene with long-term prognosis in patients after myocardial infarction. Heart Vessels (2014) 0.83
Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention. Heart Vessels (2011) 0.82
Developing points-based risk-scoring systems in the presence of competing risks. Stat Med (2016) 0.82
Left ventricular global longitudinal systolic strain predicts adverse remodeling and subsequent cardiac events in patients with acute myocardial infarction treated with primary percutaneous coronary intervention. Int J Cardiovasc Imaging (2015) 0.81
Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes. Am J Cardiovasc Dis (2013) 0.81
Higher body mass index at the time of acute myocardial infarction is associated with a favorable long-term prognosis (8-year follow-up). Heart Vessels (2011) 0.80
A new simplified immediate prognostic risk score for patients with acute myocardial infarction. Emerg Med J (2006) 0.80
A prognostic index for risk stratification for acute heart failure and death in subjects with ischemic cardiomyopathy and cardiac defibrillator. Heart Vessels (2015) 0.80
Predictive factors of short-term survival from acute myocardial infarction in early and late patients in Isfahan and Najafabad, Iran. ARYA Atheroscler (2016) 0.80
Systemic Inflammatory Response Syndrome Predicts Mortality in Acute Coronary Syndrome without Congestive Heart Failure. West J Emerg Med (2010) 0.79
A Novel Risk Stratification Model for Patients with Non-ST Elevation Myocardial Infarction in the Korea Acute Myocardial Infarction Registry (KAMIR): Limitation of the TIMI Risk Scoring System. Chonnam Med J (2011) 0.79
Time from symptom onset to treatment and outcome in prehospital thrombolysis for acute ST-elevation myocardial infarction. Neth Heart J (2002) 0.78
Time to Reperfusion: The Critical Modulator in Thrombolysis and Primary Angioplasty. J Thromb Thrombolysis (1996) 0.78
Acute coronary syndrome in patients with prior coronary artery bypass surgery: observations from a 20-year registry in a middle-eastern country. PLoS One (2012) 0.78
Streptokinase versus alteplase in acute myocardial infarction. J R Soc Med (1996) 0.78
Validation of the Killip-Kimball classification and late mortality after acute myocardial infarction. Arq Bras Cardiol (2014) 0.78
Resting heart rate and outcomes in patients with cardiovascular disease: where do we currently stand? Cardiovasc Ther (2013) 0.77
Psychosocial stress-induced heart rate reactivity and atherogenesis: cause or correlation? J Behav Med (1998) 0.77
Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA study. Clin Res Cardiol (2013) 0.77
Arterial pressure optimization in the treatment of septic shock: a complex puzzle. Crit Care (2010) 0.77
Clinical and prognostic characteristics associated with age and gender in acute myocardial infarction: a multihospital perspective in the Murcia region of Spain. Eur J Epidemiol (1999) 0.76
Thirty day prognosis of patients with acute pulmonary oedema complicating acute coronary syndromes. Heart (2005) 0.76
Identifying Patient Risk: The Basis for Rational Discharge Planning After Acute Myocardial Infarction. J Thromb Thrombolysis (1996) 0.76
Resting heart rate in first year survivors of myocardial infarction and long-term mortality: a community study. Mayo Clin Proc (2014) 0.76
Sex-related differences in prognosis after myocardial infarction: changes from 1978 to 2007. Eur J Epidemiol (2012) 0.75
Prognostic factors of in-hospital mortality in all comers with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Heart Asia (2016) 0.75
Risk assessment after acute coronary syndrome. BMJ (2006) 0.75
Earliest Bedside Assessment of Hemodynamic Parameters and Cardiac Biomarkers: Their Role as Predictors of Adverse Outcome in Patients with Septic Shock. Int J Med Sci (2015) 0.75
Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care (2013) 0.75
Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project. J Epidemiol (2016) 0.75
Infarct size as predictor of systolic functional recovery after myocardial infarction. Arq Bras Cardiol (2014) 0.75
The effect of admission creatinine levels on one-year mortality in acute myocardial infarction. ScientificWorldJournal (2012) 0.75
Explicit risk in acute coronary syndrome management. Can J Cardiol (2009) 0.75
Risk factors and clinical characteristics of in-hospital death in acute myocardial infarction with IABP support. Int J Clin Exp Med (2015) 0.75
Prognostic factors of 28 days survival rate in patients with a first acute myocardial infarction based on gender in Isfahan, Iran (2000-2009). ARYA Atheroscler (2015) 0.75
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic therapy. BMJ Open (2016) 0.75
Associations of volume and other hospital characteristics on mortality within 30 days of acute myocardial infarction in South Korea. BMJ Open (2015) 0.75
Relation between blood pressure after an acute coronary event and subsequent cardiovascular risk. Heart (2002) 0.75
Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction. J Am Heart Assoc (2016) 0.75
ACHTUNG-Rule: a new and improved model for prognostic assessment in myocardial infarction. Eur Heart J Acute Cardiovasc Care (2012) 0.75
Time to Treatment: A Crucial Factor in Thrombolysis and Primary Angioplasty. J Thromb Thrombolysis (1996) 0.75
[Class I antiarrhythmic drugs: mechanisms, contraindications, and current indications]. Herzschrittmacherther Elektrophysiol (2010) 0.75
Biases in Individualized Cost-effectiveness Analysis: Influence of Choices in Modeling Short-Term, Trial-Based, Mortality Risk Reduction and Post-Trial Life Expectancy. Med Decis Making (2017) 0.75
The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA (1996) 17.62
Evaluating the yield of medical tests. JAMA (1982) 14.05
Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA (2001) 13.93
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Regression modelling strategies for improved prognostic prediction. Stat Med (1984) 7.09
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med (1999) 6.93
Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med (1994) 6.78
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med (1997) 6.19
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA (2000) 6.00
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med (1996) 5.94
Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter? N Engl J Med (1997) 5.80
Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med (1993) 5.59
Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med (1996) 5.51
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol (1989) 5.50
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med (2001) 4.85
Isolated single coronary artery: a review of 50,000 consecutive coronary angiographies. Eur Heart J (1992) 4.59
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med (1999) 4.53
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (1999) 4.36
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med (1995) 4.29
Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med (2000) 4.19
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1999) 4.15
Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation (1998) 3.92
Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation (1996) 3.82
Association between myeloperoxidase levels and risk of coronary artery disease. JAMA (2001) 3.74
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med (1995) 3.69
Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med (1991) 3.63
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation (2000) 3.61
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA (1997) 3.51
Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation (1990) 3.49
Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment? Ann Intern Med (1992) 3.39
Outmigration for coronary bypass surgery in an era of public dissemination of clinical outcomes. Circulation (1996) 3.32
Scorecard cardiovascular medicine. Its impact and future directions. Ann Intern Med (1994) 3.32
Job strain and the prevalence and outcome of coronary artery disease. Circulation (1995) 3.22
The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. Myocardial Infarction Triage and Intervention Project Investigators. N Engl J Med (1993) 3.12
Absence of association between insurance copayments and delays in seeking emergency care among patients with myocardial infarction. N Engl J Med (1997) 3.12
Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Circulation (1998) 3.11
The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med (1995) 3.08
Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA (1992) 3.06
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med (1987) 3.04
Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol (2001) 2.99
Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet (1988) 2.90
Clinical data bases. Accomplishments and unrealized potential. Med Care (1985) 2.83
Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med (1996) 2.83
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1996) 2.81
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet (1997) 2.80
A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators. N Engl J Med (1996) 2.73
A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol (1996) 2.60
Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. J Am Coll Cardiol (1988) 2.59
Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation (1994) 2.53
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation (1995) 2.53
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med (1997) 2.52
Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Am J Med (1984) 2.49
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49
Selection of patients with acute myocardial infarction for thrombolytic therapy. Ann Intern Med (1990) 2.48
Cardiogenic shock complicating acute coronary syndromes. Lancet (2000) 2.42
Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol (1999) 2.36
Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation (1998) 2.32
Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study. Am Heart J (2001) 2.30
Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. Lancet (1997) 2.30
Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. JAMA (2001) 2.29